SynbiCITE welcomes RebelBio to London
- Posted on 6 December, 2017
We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itself. We run a crucible that transforms scientists into entrepreneurs.
On top of our cash investment, during the program, teams have access to a fully equipped biosafety level lab, co-working space, dedicated mentorship and the support of a network of RebelBio alumni, investors, corporates and press partners.
RebelBio is an SOSV Accelerator.
Apply here: https://goo.gl/iencnF
Share this article:
People also read
BBC highlight Modern Synthesis
Ben Reeve from Modern Synthesis and Tom Ellis from the Department of Bioengineering, Imperial College are featured on the One Show talking about the m...
BBC Click Combatting Cancer
BBC Click meets the scientists harnessing the power of robotics and AI to find new cancer treatments with fewer side effects. See James Field from Lab...
New Government report
UK Government report published this week entitled “Engineering Biology: Opportunities for the UK Economy and National Goals”, is an important document...